An observational study in Infertility and Male Infertility, sponsored by IRCCS San Raffaele. Recruiting at 1 site in Italy. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-12-27.
Sponsored by IRCCS San Raffaele · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Infertility, Male with a site in Italy — 9 open to participants now, 9 under way, none of them phase 3. Infertility, Male · Italy.
Among the 17 studies in Infertility, Male with a site in Italy, this one is the 7th largest by planned enrollment of the 10 observational ones that give a count, is the only one that started in 2021, is one of 10 observational ones, and was the 12th registered.
283 studies on the registry are indexed under Infertility, Male; 65 are open to participants now.
Browse Infertility, Male studies →9 of the 17 studies in Infertility, Male with a site in Italy are open now. Recruiting first, the newest first:
IRCCS San Raffaele · Sites in Italy
Ages 18–50 · Men only
IRCCS San Raffaele · Sites in Italy
Ages 18–50 · Men only · Healthy volunteers
Azienda Ospedaliero-Universitaria di Modena · Sites in Italy
Ages 18–45 · Men only
IRCCS San Raffaele · Sites in Italy
Ages 18+ · Men only · Healthy volunteers
IRCCS San Raffaele · Sites in Italy
Ages 18+ · Men only · Healthy volunteers
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 41 Infertility, Male studies recruiting now, 17 (41%) set no upper age limit and 24 (59%) stop at 75 or younger; 8 take children under 18; 15 take healthy volunteers.
This study: 18 Years and older · male.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 3 2
First in 2011; this study’s year is marked. 1 started in 2021.
This study's planned enrollment of 200 is close to the median of 182 across 87 observational studies indexed under Infertility, Male.
Median enrollment 32 across the 7 interventional studies, 575 across the 10 observational. Of the 3 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 17 has an industry lead sponsor. The 10 most frequent:
IRCCS San Raffaele is the lead sponsor of 458 studies on the registry; 237 are open to participants now.
IRCCS San Raffaele has 7 studies filed under Infertility, Male — fewer than ten, so there is no comparison to draw.
1 of the studies in Infertility, Male with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07330869Città di Lecce Hospital, GVM Care & ResearchWarfarin Effects on Male Fertility After Cardiac Surgery | 2027-02 |
Add it to your calendar (.ics) → With an account.
Among the 17 studies in Infertility, Male with a site in Italy, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
By applying a "system medicine" approach, the project aims to identify new biomarkers and/or prognostic tools aimed at developing personalized strategies to prevent the onset of comorbidities in infertile men.
By applying a "system medicine" approach, the project aims to identify new biomarkers and/or prognostic tools aimed at developing personalized strategies to prevent the onset of comorbidities in infertile men.
The findings will provide new insights into the relationship between male infertility and somatic health, and shed light on the role of the microbiome in modulating the activity of the immune system. A "signature" of lack of immunological tolerance and biomarkers could be useful to predict future oncologic and non-oncological comorbidities in infertile men. This will let the development of a more clinically reliable and cost-effective personalized primary/secondary prevention strategy in a population at high risk of clinically relevant diseases.
283 studies on the registry are indexed under Infertility, Male; 65 are open to participants now.
This study's planned enrollment of 200 is close to the median of 182 across 87 observational studies indexed under Infertility, Male.
Browse Infertility, Male studies →IRCCS San Raffaele is the lead sponsor of 458 studies on the registry; 237 are open to participants now.
Compared within Infertility, Male, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Infertility. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Fertile and infertile men according to WHO criteria (2010)
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Men with a diagnosis of pure Male Factor Infertility, as for WHO criteria
Other: Observation and evaluation of clinical parameters in the two cohorts
Fathers with at least one child, spontaneously conceived, with a time-to-pregnancy within 12 months, as for WHO criteria
Other: Observation and evaluation of clinical parameters in the two cohorts
During medical history evaluation, all factors that could negatively affect male fertility, like prevalent comorbidities, previous testis surgery, and any disorder affecting testicular function will be investigated in fertile and infertile men. Moreover, family history will be deeply investigated, including fertility status and prevalence of malignant Non Communicables Diseases. A comprehensive physical examination will be performed on each infertile and fertile man.
Medical anamnesis
Data collection on Charlson Comorbidity Index (CCI), partner's age, partner's health status;
Time frame: Baseline
Objective examination
presence of varicocele; testicular size and number
Time frame: Baseline
Testosterone
data on testosterone (ng/dL)
Time frame: Baseline
Genetic profile
Data on karyotype and microdeletions of the Y chromosome
Time frame: Baseline
Semen volume
Semen volume (ml)
Time frame: Baseline
Body mass index
Dataon Body mass index
Time frame: Baseline
Follicle-stimulating hormone
Data on follicle-stimulating hormone (mIU/ml)
Time frame: Baseline
Luteinizing hormone
Data on luteinizing hormone (mIU/dl)
Time frame: Baseline
Anti-Müllerian hormone
Data on Anti-Müllerian hormone (ng/ml)
Time frame: Baseline
Inhibin B
Data on Inhibin B (UI/mL)
Time frame: Baseline
Prolactin
Data on Prolactin (µg/l)
Time frame: Baseline
Thyroid-stimulating hormone
Data on thyroid-stimulating hormone (mU/L)
Time frame: Baseline
Osteocalcin levels
Data on osteocalcin levels (ng/ml)
Time frame: Baseline
Semen concentration
number of spermatozoa (million/ml)
Time frame: Baseline
Spermatozoa motility and morphology
motility and morphology of spermatozoa (%)
Time frame: Baseline
Plan to share: No
No publications or documents are linked to this record.
Started Jan 2021 (actual). Primary completion is estimated for Jul 2025, 54 months after the start.
Of 40 observational studies under Infertility, Male, half reached primary completion within 59 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 129. This study's planned 54 months is close to that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.